LSTA Penghasilan resik perusahaan Lisata

The profit history of Lisata Therapeutics (LSTA) demonstrates market expectations for the company. This trend captures the potential for monopoly pricing power driven by improved tumor penetration of the therapy. Trials of LBS-1 and FDA orphan drug status are fueling growth. The current peak of scientific productivity within the R&D pipeline reinforces these trends, while -0.01 reflects the latest metric value.

LSTA lisata.com: Penghasilan resik ing interval 28.04.2023 - 31.10.2026

Rincian analitis lan laporan data perusahaan lisata.com (LSTA)

- rega saham lan konsensus proyeksi valuasi:

Bagan rega Lisata Therapeutics, Inc.|LSTA - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar Lisata Therapeutics, Inc.|LSTA - Nilai Perusahaan

- data ekuitas miturut neraca:

Nilai Buku Siji Saham Lisata Therapeutics|LSTA - Aset Bersih Perusahaan|Koefisien Nilai Pasar marang Nilai Buku lisata.com|LSTA - Gunggung Aset Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Lisata Therapeutics|LSTA - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas Lisata Therapeutics, Inc.|LSTA - Utang perusahaan|Rasio utang marang kapitalisasi buku Lisata Therapeutics, Inc.|LSTA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Lisata Therapeutics|Rasio likuiditas perantara lisata.com

- data bathi bisnis lan rasio investasi:

LSTA - Bathi resik

Analisis dhasar perusahaan:Lisata, LSTA

An analysis of the commercial results of Lisata Therapeutics (LSTA) allows for an assessment of management's financial stability in developing innovative therapies for solid tumors. This indicator reflects the net remaining funds after deducting all operating expenses from revenue, transforming quarterly reports into a continuous data stream for the real-time assessment of capital efficiency during clinical trials.

Pesaing langsung

GERN (Geron Bio) - Bathi resik perusahaan|Bathi resik perusahaan Nanobiotix S.A.|Penghasilan resik perusahaan bicycletherapeutics.com BCYC|Bathi resik CTMX|perspectivetherapeutics.com (CATX) - Bathi resik taunan|Genelux - Penghasilan resik|Molecular Partners Ltd (MOLN) - Penghasilan resik perusahaan|ONCY: Penghasilan resik|Bathi pungkasan MBRX (Moleculin Biotech, Inc.)|galeratx.com (GRTX) - Bathi resik perusahaan|Bathi sawise pajeg MTEM (Molecular Templates Inc)